Home > Drug Search >
  • company_query: Azevan
  •   > 
Drug Filter
Category:
chemistry (36) biology (7)
Status:
Approved (5) Withdrawn (1) NDA Filing (3) Phase Ⅲ (8) Phase Ⅱ (16) Phase Ⅰ (10)
Clinical Stage:
Pending (6) Active (18) Discontinued (13)
Bio-Type:
Vaccine (2) Recombinant enzyme (1) Recombinant cytokines (3) Fusion protein (1)
Indication:
Asthma (2) Atrial fibrillation (1) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (1) Oedema (1) Chronic idiopathic constipation (CIC) (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (3) Cognitive disorders (3) Diabetic nephropathy (1) Duodenal ulcer (1) Dysmenorrhea (1) Dyspepsia (1) Erosive esophagitis (EE) (1) Friedreich's ataxia (1) Gastric cancer (2) Gastroesophageal reflux disease (GERD) (1) Cytomegalovirus infections (1) Heart failure (1) HIV infection (2) Hypertension (1) Influenza virus infection (1) Lung cancer (1) Malignant brain tumor (1) Myocardial infarction (MI) (1) Neuropathic pain (1) Niemann-Pick diseases (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Solid tumours (2) Tardive dyskinesia (1) Tuberculosis (2) Type 2 diabetes (3) Colorectal cancer (1) Chronic heart failure (1) Diabetes (1) Neutropenia (3) Renal carcinoma (1) Septic shock (1) Pruritus (1) Intermittent explosive disorder (1) Smallpox infection (1) Adenovirus infection (1) Ischemic stroke (1) Esophagus cancer (1) Intermittent claudication (1) Bacterial infection (1) Liver cancer (1) Ocular pain (1) Ocular inflammation (1)
Aprv. Year:
 (1) 1999 (1) 2010 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top